Search This Blog

Friday, February 27, 2026

Xeris Biopharma sues Torrent, Somerset to block generic versions of Recorlev

 

 under Hatch-Waxman

  • Subsidiaries filed patent infringement suit in New Jersey federal court, seeking to block generics until March 2040.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)